Skip to main content
CHINA BAOAN GROUP CO., LTD. logo

CHINA BAOAN GROUP CO., LTD. — Investor Relations & Filings

Ticker · 000009 ISIN · CNE000000222 LEI · 300300SWCZND4GQFVP61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,042 across all filing types
Latest filing 2026-05-19 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000009

About CHINA BAOAN GROUP CO., LTD.

https://www.chinabaoan.com

China Baoan Group Co., Ltd. operates as a multi-sector enterprise with core interests in high-tech manufacturing, healthcare, and urban development. The company is a prominent provider of new energy materials, specifically focusing on the research and production of anode and cathode materials for lithium-ion batteries used in electric vehicles and energy storage systems. Its pharmaceutical division specializes in the development and distribution of traditional Chinese medicines and specialized healthcare products. Furthermore, the group manages a portfolio of real estate projects and property services. Through its diverse subsidiaries, the organization integrates industrial operations with strategic investment to support technological advancement in the energy and medical sectors.

Recent filings

Filing Released Lang Actions
关于下属子公司与专业投资机构共同投资的公告
Capital/Financing Update Classification · 82% confidence The document is an official announcement by China Bao’an Group regarding its subsidiary’s co-investment with professional investors to set up a private equity fund. It details the fund structure, capital commitments, partners, and investment terms. This is not a financial report, earnings release, or management change notice but rather an announcement of a financing/investment activity by the company. This fits the definition of a Capital/Financing Update (CAP).
2026-05-19 Chinese
关于下属子公司签署股权转让合同的进展公告
Regulatory Filings
2026-05-08 Chinese
关于使用自有资金进行委托理财的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by China Baoan Group Co., Ltd. regarding the use of its own funds for entrusted financial management (委托理财). It details the amount, purpose, risk analysis, and approval procedures related to the entrusted financial products. The document is relatively short (1364 characters) and focuses on informing shareholders and the public about a financing-related activity involving the company's own funds. It does not contain financial statements, earnings data, or detailed financial analysis. It is not a full financial report, audit report, or earnings release. The content fits best under Capital/Financing Update (CAP) as it relates to the company's capital management and financing activities through entrusted financial products.
2026-04-24 Chinese
上市公司非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 90% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the year 2025, prepared by a company. It contains financial data such as balances, amounts occupied, interest, and repayments related to related parties and subsidiaries. The document is 5537 characters long, which is sufficient to contain substantive financial data. It is not an announcement or a brief summary but a detailed financial table. There is no indication that this is an annual report, audit report, or earnings release. The content focuses on related party transactions and fund occupation, which is typically part of regulatory disclosures or financial supplements but does not fit neatly into categories like Annual Report or Interim Report. Given the detailed financial data and the nature of the content, it aligns best with Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. Therefore, the classification is RNS with high confidence.
2026-04-24 Chinese
2025年度董事局工作报告
Board/Management Information Classification · 95% confidence The document is titled as the "2025年度董事局工作报告" which translates to the "2025 Board of Directors Work Report". It contains detailed descriptions of the board's activities, meetings, resolutions, governance improvements, and plans for the next year. It includes summaries of financial performance but is primarily focused on the board's work and governance rather than presenting full financial statements or detailed financial analysis. The document also lists board meetings and shareholder meetings with their agendas, which is typical for a board or management report. The length is 4599 characters, which is substantial but not a full annual report or interim report. It is not a simple announcement or certification. Therefore, the document best fits the category of Board/Management Information (MANG).
2026-04-24 Chinese
关于下属子公司开展外汇衍生品套期保值业务的可行性分析报告
Capital/Financing Update Classification · 95% confidence The document is a detailed feasibility analysis report regarding the subsidiary companies' engagement in foreign exchange derivative hedging business. It discusses the background, necessity, risk analysis, risk control measures, and concludes on the feasibility of conducting such derivative transactions. The content is focused on operational and financial risk management related to foreign exchange derivatives, not on financial results, audit opinions, or regulatory filings. It is not an announcement, certification, or a brief summary but a substantive report analyzing a specific financial activity. This type of document fits best under the category of Capital/Financing Update (CAP), as it relates to the company's financing activities and risk management strategies involving derivatives and capital management.
2026-04-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.